Bolivia vs Syria: Cause of death, by non-communicable diseases, ages 5-14, male
Bolivia
25.6%
in 2021
Syria
25.1%
in 2021
Bolivia rank
123rd
Syria rank
126th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Bolivia
- Syria
How they compare
Bolivia currently reports 25.6% against 25.1% in Syria, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Syria ahead.
Bolivia ranks 123rd and Syria ranks 126th of 185 countries.
Across the 3 decades both report, Bolivia averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Bolivia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.2% | 42.7% | 13.5% | Syria |
| 2010s | 32.2% | 21.2% | 11.0% | Bolivia |
| 2020s | 28.0% | 25.4% | 2.7% | Bolivia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Bolivia or Syria?
- Bolivia, at 25.6% against 25.1% in Syria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Bolivia and Syria?
- 0.5%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Bolivia and Syria rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Bolivia ranks 123rd and Syria ranks 126th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.